TRI vs XYL: Which Stock Is the Better Buy?
Thomson Reuters Corporation and Xylem Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Industrials.
AI verdict — TRI vs XYL, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Thomson Reuters Corporation (TRI) | Xylem Inc. (XYL) | |
|---|---|---|
| Market cap | $34.7B | $29.2B |
| Revenue (latest FY) | $7.48B | $9.04B |
| Net income (latest FY) | $1.50B | $957.00M |
| Revenue growth (5y CAGR) | 4.1% | 13.1% |
| Net margin | 20.1% | 10.6% |
| Return on equity | 12.6% | 8.3% |
| P/E ratio | 22.8 | 30.6 |
| Dividend yield | 3.2% | 1.4% |
| Profitable years (of last 10) | 4 | 10 |
| Positive free cash flow | Yes | Yes |
See the full TRI vs XYL breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open TRI's full financials → Open XYL's full financials →Frequently asked questions
Which is bigger, TRI or XYL?
Thomson Reuters Corporation is larger by market capitalization — $34.7B versus $29.2B.
Which grows faster, TRI or XYL?
Over the last five fiscal years, Xylem Inc. grew revenue faster — 13.1%/yr versus 4.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.